Login

Ben McMillan, founder and CIO of IDX Digital Assets, discusses the key factors driving the crypto market in an interview with CNBC Crypto World. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Global Markets Rebound: Invesco's Asia-Pacific Journey Post-Pandemic | Andrew Schlossberg , CEO , Invesco.
00:10:00
Diversifying Wealth: Srikanth Narayan on Managing Concentrated Stock with Exchange Funds
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Analyzing Coronation Fund Managers: Navigating Growth and Market Dynamics | Anton Pillay , CEO, South Africa Coronation Fund Managers.
00:10:00
Warren Owen Discusses Commodities and Electrification in Mining Sector
00:10:00
Arrow Electronics CEO tells the Key to Success | Morten Kreiberg-Block, CEO, Arrow Electronics IncARWS:STU
00:10:00
Tom Lydon interviews David Mazza, Head of ETF Investment Strategy at State Street Global Advisors, exploring insights into ETF investment strategies.|Yie-Hsin Hung is president and chief executive officer of State Street Global Advisors
00:10:00
Roscan Gold CEO Nana Sangmuah Discusses Drilling Successes and Strategic Partnerships at Candioli Project in Mali
00:10:00
Casius Mining's Promising Gold Exploration in Ghana: Insights from James at the One-to-One Conference
00:10:00
Joymode is enabling rental commerce for the good of consumers and the planet|Al Sambar,General Partner,XRC Labs
00:10:00
Interview with Hedley Widdup, Investment Manager at Lion Selection Group: Market Insights and Investment Clock
00:10:00
Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies.

© 2026 Nehu